(Q53366008)
Statements
INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. (English)
Cohen J
Carlet J
1 September 1996
24
9
1431-1440